A pragmatic trial of ambulatory toxicity management in patients receiving ddjuvant or neo-adjuvant chemotherapy for early stage breast cancer

Last updated February 28 2016, this trail is a comparison of the number of ER plus hospital visits that occurred during chemotherapy between the telephone intervention and control arms. Using a pragmatic cluster-randomized trial design, 20 Ontario cancer centres that provide care to patients with breast cancer will be randomly allocated to one of two arms: pro-active telephone toxicity management (intervention), or control (routine care). Read more about the trial here.